UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

SAMHD1: At the Crossroads of Cell Proliferation, Immune Responses, and Virus Restriction

Trends in microbiology (Regular ed.), 2015-11, Vol.23 (11), p.680-692

2015

Link zum Volltext

Verfügbarkeit prüfen

Current status and challenges of antiretroviral research and therapy

Antiviral research, 2010, Vol.85 (1), p.25-33

2010

Link zum Volltext

Verfügbarkeit prüfen

HIV entry inhibitors

The Lancet (British edition), 2007-07, Vol.370 (9581), p.81-88

2007

Link zum Volltext

Verfügbarkeit prüfen

Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells

The Journal of immunology (1950), 2014-08, Vol.193 (4), p.1988-1997

2014

Link zum Volltext

Verfügbarkeit prüfen

CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir

Nature communications, 2018-07, Vol.9 (1), p.2739-10, Article 2739

2018

Link zum Volltext

Verfügbarkeit prüfen

Endocytosis of HIV: anything goes

Trends in microbiology (Regular ed.), 2010-12, Vol.18 (12), p.543-551

2010

Link zum Volltext

Verfügbarkeit prüfen

The G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells

PLoS pathogens, 2016-08, Vol.12 (8), p.e1005829-e1005829

2016

Link zum Volltext

Verfügbarkeit prüfen

RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages

Scientific reports, 2017-10, Vol.7 (1), p.13339-14, Article 13339

2017

Link zum Volltext

Verfügbarkeit prüfen

Indolylarylsulfones Carrying a Heterocyclic Tail as Very Potent and Broad Spectrum HIV‑1 Non-nucleoside Reverse Transcriptase Inhibitors

Journal of medicinal chemistry, 2014-12, Vol.57 (23), p.9945-9957

2014

Link zum Volltext

Verfügbarkeit prüfen

Zinc Finger Endonuclease Targeting PSIP1 Inhibits HIV-1 Integration

Antimicrobial agents and chemotherapy, 2014-08, Vol.58 (8), p.4318-4327

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of α‑Methoxy Substitution on the Anti-HIV Activity of Dihydropyrimidin-4(3H)‑ones

Journal of medicinal chemistry, 2019-01, Vol.62 (2), p.604-621

2019

Link zum Volltext

Verfügbarkeit prüfen

Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV‑1 Agents

Journal of medicinal chemistry, 2017-08, Vol.60 (15), p.6528-6547

2017

Link zum Volltext

Verfügbarkeit prüfen

Palbociclib, a selective inhibitor of cyclin-dependent kinase4/6, blocks HIV-1 reverse transcription through the control of sterile α motif and HD domain-containing protein-1 (SAMHD1) activity

AIDS (London), 2014-09, Vol.28 (15), p.2213-2222

2014

Link zum Volltext

Verfügbarkeit prüfen

ADS-J1 Inhibits HIV-1 Entry by Interacting with gp120 and Does Not Block Fusion-Active gp41 Core Formation

Antimicrobial Agents and Chemotherapy, 2010-10, Vol.54 (10), p.4487-4492

2010

Link zum Volltext

Verfügbarkeit prüfen

New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains

European journal of medicinal chemistry, 2020-12, Vol.208, p.112696-112696, Article 112696

2020

Link zum Volltext

Verfügbarkeit prüfen

New Nitrogen Containing Substituents at the Indole-2-carboxamide Yield High Potent and Broad Spectrum Indolylarylsulfone HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Journal of medicinal chemistry, 2012-07, Vol.55 (14), p.6634-6638

2012

Link zum Volltext

Verfügbarkeit prüfen

ADAR1 affects HCV infection by modulating innate immune response

Antiviral research, 2018-08, Vol.156, p.116-127

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir

Antimicrobial agents and chemotherapy, 2017-11, Vol.61 (11)

2017

Link zum Volltext

Verfügbarkeit prüfen

Restriction of HIV-1 replication in primary macrophages by IL-12 and IL-18 through the upregulation of SAMHD1

The Journal of immunology (1950), 2013-05, Vol.190 (9), p.4736-4741

2013

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1

Journal of antimicrobial chemotherapy, 2016-02, Vol.71 (2), p.387-394

2016

Link zum Volltext

Verfügbarkeit prüfen

The thioacetate-ω(γ-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent

Antiviral research, 2015-11, Vol.123, p.62-69

2015

Link zum Volltext

Verfügbarkeit prüfen

Diarylpyrimidine−Dihydrobenzyloxopyrimidine Hybrids: New, Wide-Spectrum Anti-HIV-1 Agents Active at (Sub)-Nanomolar Level

Journal of medicinal chemistry, 2011-04, Vol.54 (8), p.3091-3096

2011

Link zum Volltext

Verfügbarkeit prüfen

Targeting HIV-1 RNase H: N' -(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants

Viruses, 2020-07, Vol.12 (7), p.729

2020

Link zum Volltext

Verfügbarkeit prüfen

Insights from host genomics into HIV infection and disease: Identification of host targets for drug development

Antiviral research, 2013-11, Vol.100 (2), p.473-486

2013

Link zum Volltext

Verfügbarkeit prüfen

Nucleotide embargo by SAMHD1: A strategy to block retroviral infection

Antiviral research, 2013-02, Vol.97 (2), p.180-182

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(229)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(169)
Life Sciences & Biomedicine
(157)
Humans
(146)
Pharmacology & Pharmacy
(77)
Human Immunodeficiency Virus 1
(61)
Hiv-1 - Drug Effects
(60)
Biological And Medical Sciences
(58)
Virology
(58)
Anti-Hiv Agents - Pharmacology
(54)
Medical Sciences
(53)
Infectious Diseases
(46)
Antiviral Agents
(43)
Cell Line
(43)
Human Immunodeficiency Virus
(41)
Pharmacology. Drug Treatments
(40)
Immunology
(39)
Chemistry, Medicinal
(38)
Hiv-1 - Physiology
(37)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(36)
Hiv-1
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

SAMHD1: At the Crossroads of Cell Proliferation, Immune Responses, and Virus Restriction

Current status and challenges of antiretroviral research and therapy

HIV entry inhibitors

Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells

CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir

Endocytosis of HIV: anything goes

The G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells

RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages

Indolylarylsulfones Carrying a Heterocyclic Tail as Very Potent and Broad Spectrum HIV‑1 Non-nucleoside Reverse Transcriptase Inhibitors

Zinc Finger Endonuclease Targeting PSIP1 Inhibits HIV-1 Integration

Effect of α‑Methoxy Substitution on the Anti-HIV Activity of Dihydropyrimidin-4(3H)‑ones

Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV‑1 Agents

Palbociclib, a selective inhibitor of cyclin-dependent kinase4/6, blocks HIV-1 reverse transcription through the control of sterile α motif and HD domain-containing protein-1 (SAMHD1) activity

ADS-J1 Inhibits HIV-1 Entry by Interacting with gp120 and Does Not Block Fusion-Active gp41 Core Formation

New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains

New Nitrogen Containing Substituents at the Indole-2-carboxamide Yield High Potent and Broad Spectrum Indolylarylsulfone HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

ADAR1 affects HCV infection by modulating innate immune response

Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir

Restriction of HIV-1 replication in primary macrophages by IL-12 and IL-18 through the upregulation of SAMHD1

Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1

The thioacetate-ω(γ-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent

Diarylpyrimidine−Dihydrobenzyloxopyrimidine Hybrids: New, Wide-Spectrum Anti-HIV-1 Agents Active at (Sub)-Nanomolar Level

Targeting HIV-1 RNase H: N' -(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants

Insights from host genomics into HIV infection and disease: Identification of host targets for drug development

Nucleotide embargo by SAMHD1: A strategy to block retroviral infection

Suchergebnisse filtern